All News

Tagrisso (osimertinib) had positive outcomes for patients with T790M-positive non–small cell lung cancer (NSCLC) for central nervous system (CNS) metastases.

Adding Perjeta (pertuzumab) to postoperative Herceptin (trastuzumab) improved survival in certain patients with breast cancer.

As any cancer survivor is aware, the blossom of hope can be a fragile flower.

Don’t let cancer keep you from your reaching your goals, ever.

Superfoods provide substances that shield our body from damage

Resources are available to help patients with cancer better manage nutrition.

Self-esteem and body image suffer after a breast cancer diagnosis. Finding a way to move past the trauma is challenging for some.

You’ve probably heard a lot of buzz about how healthy certain foods are good for you, but they're not the end all be all of a healthy diet.

There may be an upcoming shift in the treatment paradigm of patients with EGFR+ and ALK+ lung cancer.

Fatigue is one of the most common complaints of patients.

Complementary therapies can make a difference in the cancer journey, and now we have to get oncologists to accept them

Combined modality treatment (CMT) could be considered a first course of treatment for patients with muscle-invasive bladder cancer, according to the authors of a recent study published in the International Journal of Radiation Oncology.

Patients with squamous cell carcinoma of the head and neck (SCCHC) and those with melanoma saw some promising activity with the drug combination of epacadostat and Opdivo (nivolumab), according to findings from the phase 1/2 ECHO-204 study presented at the 2017 ASCO Annual Meeting.

Little did I know, yoga would play a huge role in my life and recovery from breast cancer.

How your response in a medical crisis can impact loved ones

Maybe they'll be able to put the big girl pants on when life throws it's curve balls.

Even cereals with healthy-sounding names don’t quite make the mark.

A new study published in Cancer Medicine examined the long-term health-related effects of definitive treatment for patients with localized prostate cancer and found that they continue more than 10 years after treatment.

Taking time to show apprecitaion and graitude to the giants of oncology and all that they do

Some newly diagnosed patients with prostate cancer reduced their risk of death with earlier use of Zytiga, according to two trials presented at the ASCO Annual Meeting.

Opdivo (nivolumab) plus Yervoy (ipilimumab) demonstrated a response in some patients with melanoma brain metastases, according to a recent study presented at ASCO.

How writing helped me deal with the effects of cancer.

Soy remains an important and somewhat contentious health topic.

Chemobrain is more than being lazy or forgetful sometimes.

A recent study proved an online program to be helpful in reducing anxiety in many newly diagnosed patients.

Becoming pregnant does not increase a woman's chance of having her breast cancer recur, according to a recent study presented at ASCO.

VYXEOS (CPX-351), a novel injection, was granted a new drug application (NDA) by the Food and Drug Administration (FDA), granting the drug a priority review for the treatment of acute myeloid leukemia (AML), according to Jazz Pharmaceuticals, the producer of the drug.

Researchers found that nearly 75 percent of sunscreen products contain less SPF than labeled, and the Environmental Working Group (EWG) is working to have that changed.